Skip to content

Clinical trials

Phase 2 Disease Progression trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Phase: Phase 2 Country / region: France Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20111
20131
20151
20181
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
ARCAGY/ GINECO GROUP1
Centre Leon Berard1
Ferrer Internacional S.A.1
Institut du Cancer de Montpellier - Val d'Aurelle1
Janssen-Cilag International NV1
ThromboGenics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression8
Recurrence2
Bone Marrow Neoplasms1
Diabetic Retinopathy1
Fallopian Tube Neoplasms1
Head and Neck Neoplasms1
Multiple Myeloma1
Neoplasm Metastasis1
Neuroendocrine Tumors1
Ovarian Neoplasms1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.